Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACB vs Periarticular Infiltration in Total Knee Arthroplasty
NCT02784041Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in osteoarthritis (OA), sponsored by Peking Union Medical College Hospital. Primary endpoint: Time required for functional recovery at 7 days. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02784041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784041.